Abbvie INC (ABBV) Holder Visionary Asset Management INC Has Decreased Its Holding

747,318 shares of the company's stock traded hands, compared to its average volume of 7,246,250. BMO Capital Markets lowered shares of AbbVie from a "market perform" rating to an "underperform" rating and reduced their price target for the company from $125.86 to $84.00 in a report on Monday, January 29th. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. The institutional investor held 100,793 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $14.08 million, up from 96,711 at the end of the previous reported quarter. The stock decreased 0.31% or $0.29 during the last trading session, reaching $91.83. About 747,618 shares traded. $2.95M worth of AbbVie Inc. ABBV outperformed by 27.65% the S&P 500.

Investors sentiment increased to 1.15 in Q4 2017. Its down 0.05, from 0.85 in 2017Q3. Parkside Bank & Trust Trust, Missouri-based fund reported 753 shares.

Sumitomo Mitsui Trust Holdings Inc. grew its stake in shares of AbbVie Inc. The institutional investor held 61,529 shares of the consumer electronics and appliances company at the end of 2017Q4, valued at $1.07 million, down from 102,333 at the end of the previous reported quarter. Front Barnett Assoc Limited Liability Corp holds 0.13% or 8,288 shares in its portfolio. Fiera Cap has invested 0.12% in AbbVie Inc. Roundview Capital Lc invested in 0.36% or 14,487 shs. Mitchell Mcleod Pugh And Williams owns 6,135 shares. Clearbridge Investments Ltd Company holds 0% or 12,835 shares. Blackhill Capital Inc who had been investing in Abbvie Inc Com for a number of months, seems to be less bullish one the $145.71 billion market cap company. Hardman Johnston Glob Advsr Ltd Liability stated it has 49,608 shs or 0.2% of all its holdings. Amer Natl Registered Investment Advisor accumulated 9,671 shares. (NASDAQ:ADSK). Falcon Edge LP holds 3.45% or 143,800 shares. (NASDAQ:ADSK). Strategy Asset Managers Ltd Liability Corporation invested 0.52% of its portfolio in Autodesk, Inc. The Massachusetts-based Eaton Vance Mngmt has invested 0.16% in BB&T Corporation (NYSE:BBT). Bradley Foster & Sargent Ct owns 163,426 shares for 0.57% of their portfolio. Insight Enterprises, Inc. (NASDAQ:NSIT) has declined 16.69% since April 17, 2017 and is downtrending. Also, VP Robert A. Michael sold 992 shares of the stock in a transaction on Tuesday, February 20th. 8,280 shares valued at $976,084 were sold by GONZALEZ RICHARD A on Wednesday, February 28. Private Wealth Ptnrs stated it has 7,450 shares or 0.13% of all its holdings. The shares were sold at an average price of $64.25, for a total transaction of $4,627,028.00. (NYSE:ABBV) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. Therefore 47% are positive. As per Wednesday, September 20, the company rating was downgraded by Goldman Sachs. The firm has "Outperform" rating given on Friday, February 5 by William Blair. The stock has "Buy" rating by Jefferies on Friday, January 26. As per Tuesday, November 24, the company rating was initiated by Piper Jaffray. Jefferies maintained the shares of ABBV in report on Monday, February 26 with "Buy" rating. (NYSE:ABBV). 22,725 were reported by Auxier Asset Management. The rating was maintained by UBS on Friday, October 13 with "Neutral". The firm has "Neutral" rating given on Wednesday, November 1 by JP Morgan. It is down 0.00% since April 17, 2017 and is. Its down 0.05, from 0.85 in 2017Q3.

Gamble Jones Investment Counsel reduced its holdings in shares of AbbVie Inc. 448 rose stakes while 139 funds bought stakes. Ffcm LLC now owns 1,539 shares of the company's stock valued at $111,000 after purchasing an additional 963 shares during the last quarter. Following the completion of the transaction, the executive vice president now owns 133,026 shares in the company, valued at approximately $15,230,146.74.

AbbVie Inc (AbbVie) is a research-based biopharmaceutical company. Fundx Inv Gp Inc Limited Liability owns 0.93% invested in AbbVie Inc. (NYSE:ABBV) shares were sold by RICHMOND TIMOTHY J. Anagnost Andrew had sold 20,499 shares worth $2.57M on Thursday, March 29. 20,437 were reported by Of Virginia Va. SunTrust maintained AbbVie Inc. (NYSE:ABBV) for 42,059 shares. (NASDAQ:ADSK). Ally Incorporated reported 0.1% stake. Tradewinds Cap Mgmt Ltd Liability Corp, a Washington-based fund reported 2,271 shares. Geode Mgmt Ltd has 315,416 shares for 0% of their portfolio. Iowa Bancorp reported 2.86% stake. Connors Investor Svcs invested 1.09% of its portfolio in AbbVie Inc. (NYSE:ABBV). Fund Evaluation Group Limited Liability holds 0.17% in AbbVie Inc. Nichols And Pratt Advisers Llp Ma has 20,780 shares.

Among 13 analysts covering AbbVie (NYSE:ABBV), 6 have Buy rating, 1 Sell and 6 Hold. Therefore 40% are positive. The business's revenue for the quarter was up 13.9% compared to the same quarter last year. equities analysts forecast that AbbVie Inc. will post 7.53 EPS for the current year. The firm has "Sell" rating by Zacks given on Friday, August 28. The company was maintained on Tuesday, December 5 by Leerink Swann. The rating was initiated by Leerink Swann on Tuesday, October 18 with "Mkt Perform". The stock of Insight Enterprises, Inc. (NYSE:ABBV) on Friday, September 15 with "Buy" rating. As per Thursday, August 4, the company rating was downgraded by Raymond James.

The company also recently announced a quarterly dividend, which will be paid on Monday, May 15th. The rating was maintained by Jefferies with "Buy" on Monday, May 29. ALBAN CARLOS sold $9.57 million worth of stock. 18,300 shares valued at $1.66 million were sold by Gosebruch Henry O on Monday, October 30. SALEKI-GERHARDT AZITA also sold $157,458 worth of AbbVie Inc. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since April 17, 2017 and is uptrending.

In related news, insider Laura J. Schumacher sold 25,000 shares of the company's stock in a transaction on Thursday, March 1st.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Latest news

Analyst at Citigroup Reiterated The Wpp (LON:WPP) "Buy" Rating They've Had
Ten investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. Deutsche Bank reissued their hold rating on shares of WPP (LON: WPP ) in a report published on Monday morning.

Will Prince William be named King this week?
At the last Commonwealth Heads of Government Meeting (CHOGM) in Malta in 2015, she had endorsed for Charles to continue her role. The 53 leaders of the Commonwealth may decide this week if Prince Charles will become their next head upon the Queen's death.

Procter & Gamble (PG) Getting Somewhat Favorable News Coverage, Analysis Shows
Other large investors also recently modified their holdings of the company. 48 funds opened positions while 114 raised stakes. After this sale, 63,409 common shares of PG are directly owned by the insider, with total stake valued at $4,984,581.

Jordan Peele Teams With BuzzFeed for Obama Fake-News Awareness Video
That is until the screen is split to reveal actor and director Jordan Peele delivering his famous Obama impression. Peele's fake Obama says that "Ben Carson is in the sunken place", referring to his Oscar-winning movie Get Out .

Herbalife Ltd. (HLF) Receives $78.00 Consensus Price Target from Brokerages
Zacks Investment Research cut Herbalife from a "hold" rating to a "sell" rating in a report on Wednesday, January 4th. Xact Kapitalforvaltning AB bought a new stake in shares of Herbal Center in the fourth quarter worth about $380,000.

Other news